Secretion of interferon-α/β by splenic and bone marrow–derived dendritic cells
Sample and treatment . | Experiment no. . | IFN-α/β, U/106 cells . |
---|---|---|
BM-DCs | ||
None | 1 | 8 |
None | 2 | 8 |
sDCs | ||
None | 1 | 16 |
Anti–IFN-α/β | 1 | < 4 |
None | 2 | 8 |
Anti–IFN-α/β | 2 | < 4 |
None | 3 | 16 |
Anti–IFN-α/β | 3 | < 4 |
Sample and treatment . | Experiment no. . | IFN-α/β, U/106 cells . |
---|---|---|
BM-DCs | ||
None | 1 | 8 |
None | 2 | 8 |
sDCs | ||
None | 1 | 16 |
Anti–IFN-α/β | 1 | < 4 |
None | 2 | 8 |
Anti–IFN-α/β | 2 | < 4 |
None | 3 | 16 |
Anti–IFN-α/β | 3 | < 4 |
CD11c+ populations were isolated from the spleens of B6 mice (sDCs) and from 10- to 14-day cultures of bone marrow cells from B6 mice (BM-DCs). One million DCs were plated in each well of a 96-well culture plate in a volume of 200 μL, in the presence or absence of 1000 neutralizing units of antimouse IFN-α/β sheep immunoglobulin. Cultures were incubated at 37°C in 5% CO2 for 18 hours, after which supernatant was harvested. An aliquot of 100 μL or 50 μL of each sample was assayed for IFN-α/β activity. Data represent the IFN-α/β titer in each individual experiment, expressed in experimental units of IFN-α/β per 106 cells. One of these units is the equivalent of 4 international IFN units. IFN indicates interferon; BM-DC, bone marrow–derived dendritic cell; sDC, splenic DC.